to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Scientific researchers -- and their ideas -- will benefit from a new National Science Foundation effort to bring innovative ideas to market. The NSF Innovation Corps will fund 100 projects a year.
This finance expert explains the Sarbanes-Oxley (SOX) law and how it impacts public and private companies. This author shows the upside and downside of SOX compliance and asserts private companies aiming to grow (and go public) should take steps to become SOX-compliant early on.
This is a sample term sheet for a Series B round of financing.
This sample term sheet for a Series A round of financing details the major points of a hypothetical investment deal for a first-round ?Series A Convertible Preferred Stock? financing.
Raising money by selling equity to investors is a rare activity for companies, says CommonAngels' James Geshwiler. Not many CEOs get much practice or guidance on how to do this key task. This document is a sample template for entrepreneurs to use in pitching their companies to angel investors, and covers six main areas of risk and ability to generate return for investors.
Along with this sample Income Statement for a year old business, this tool provides a line-by-line explanation of the most common categories used to report profits.
Review this sample Cash Flow Report and Cash Flow Statement for this year old business to understand the primary differences in these two reports and the value in using them in reporting financial information.
Along with this sample Balance Sheet for a year old business, this tool provides a line-by-line explanation of the most common categories used to report the value of the company's assets, liabilities, and equity.
In the past, reverse mergers were associated with penny stocks, manipulation, and potential for abuse. Today they are viewed as a legitimate vehicle for going public. The author explains the steps involved in doing a reverse merger and offers tips for expediting filing and approval of documents with the SEC.
Regenerative medicine has come a long way in recent years, leading some venture capitalists to consider investing in it. The roadblock to investing in this field is not a lack of funds, but rather a lack of a clear explanation of regenerative medicine's commercial applications, says one former venture capitalist.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.